2024 annual financial data
Beam Therapeutics 2024 Net margin
Direct answer
Net margin was -593.13%.
Operating income was -415,568,000 USD and net income was -376,742,000 USD.
Operating cash flow was -347,246,000 USD.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 63,518,000 USD
- Operating income
- -415,568,000 USD
- Net income
- -376,742,000 USD
- Operating cash flow
- -347,246,000 USD